PRME
Prime Medicine, Inc.
$3.68+0.01 (0.27%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Prime Medicine, Inc. (PRME) is a publicly traded company with 4 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 4 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 81 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-18 | 2026-04-16 | Makhni Svetlana Ni | CFO | Award | 800,000 | $3.67 | $2,936,000 | N/A | N/A |
| 2026-02-27 | 2026-02-26 | Reine Allan | CEO | Award | 1,300,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-24 | 2026-02-23 | Lee Ann L. | CTO | Award | 375,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-24 | 2026-02-23 | Alenson Carman | See Remarks | Award | 140,000 | $0.00 | $0 | N/A | N/A |
| 2025-08-05 | 2025-08-01 | Cahill Thomas | Director | Award | 45,000 | $0.00 | $0 | N/A | N/A |
| 2025-08-05 | 2025-08-01 | Chung Wendy | Director | Disposition | 13,510 | $0.00 | $0 | N/A | N/A |
| 2025-08-05 | 2025-08-01 | Kelly Michael Aaron | Director | Disposition | 45,000 | $0.00 | $0 | N/A | N/A |
| 2025-08-05 | 2025-08-01 | Schenkein David P | Director | Award | 39,062 | $0.00 | $0 | N/A | N/A |
| 2025-08-05 | 2025-08-01 | Marrazzo Jeffrey D | Director | Award | 250,000 | $0.00 | $0 | N/A | N/A |
| 2025-08-05 | 2025-08-01 | Cahill Thomas | Director | Disposition | 39,062 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.